Close Menu

NEW YORK (GenomeWeb) – The Windber Medical Center (WMC) and Windber Research Institute (WRI) today announced definitive agreements with the Chan Soon-Shiong Institute of Molecular Research Institute to create an integrated healthcare organization. 

As part of the agreement, a precision cancer research and treatment institute will be created at WMC and WRI, the Windber facilities said, adding its vision is to make WMC and WRI "dedicated molecular medicine and genomic research institutions and centers of excellence for studying cancer and other diseases." 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Sponsored by
Qiagen: Nov 16, 2014

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.

Sponsored by
Thermo Fisher Scientific

This webinar will provide a first-hand look at how a molecular laboratory validated and implemented a targeted next-generation sequencing-based myeloid assay to expedite the assessment of myeloid malignancies and assist in the understanding of myeloid cancers.

Sponsored by
Horizon Discovery

This webinar will provide an overview of alternatives to the popular Cas9 nuclease used in CRISPR gene editing.